A Study to Evaluate the Effect of Food on the Pharmacokinetics of VX-548

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 3, 2023

Primary Completion Date

October 30, 2023

Study Completion Date

November 8, 2023

Conditions

Pain

Interventions

DRUG

VX-548

Tablets for oral administration.

Trial Locations (1)

ICON Salt Lake City, Salt Lake City

All Listed Sponsors

lead

Vertex Pharmaceuticals Incorporated

INDUSTRY

NCT05851157 - A Study to Evaluate the Effect of Food on the Pharmacokinetics of VX-548 | Biotech Hunter | Biotech Hunter